Intra-CA1 injection of orexin receptors antagonism attenuates the stress-induced analgesia in a rat acute pain model

dc.contributor.authorGhalebandi, Seyedehdelaram
dc.contributor.authorZareie, Fatemeh
dc.contributor.authorAskari, Kobra
dc.contributor.authorYuzugulen, Jale
dc.contributor.authorHaghparast, Abbas
dc.date.accessioned2026-02-06T18:37:17Z
dc.date.issued2022
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractOrexins or hypocretins are excitatory neumpeptides predominantly produced by neuronal clusters in the lateral hypothalamus. The orexinergic system's involvement in pain modulation makes it a candidate for pain control alternative to the opioid system. Moreover, orexin-1 and orexin -2 receptors (OX1r and OX2r, respectively) play a role in responsiveness to stressful stimuli. Some evidence indicates that the Cornu Ammonis 1 (CA1) region of the hippocampus potentially participates in the modulation of both pain and stress. In quest of better understanding the interaction between orexin receptors and stress-induced analgesia (SIA), The present study examined the involvement of OX1r and OX2r within the CAl in response to acute pain after exposure to forced swim stress (FSS) for a 6-min period. Adult male Wistar rats received different doses of OX1r antagonist (5B334867; 1, 3, 10, and 30 nmol), OX2r antagonist (TCS OX2 29; 3, 10, 30 and 100 nmol), or vehicle (0.5 mu l DMSO) through an implanted cannula. After that, animals individually experienced acute pain by performing the tail-flick test. Results indicated that FSS produces antinociceptive responses in the tail-flick test. Blockade of both orexin receptors within the CA1 region attenuated the analgesic effect of FSS. The antinociceptive effect of swim stress was prevented by lower doses of SB334867 than TCS OX2 29. These findings show that the orexinergic system might be partially involved in the SIA via the OX1 and OX2 receptors in the hippocampal CA1 region.
dc.description.sponsorshipShahid Beheshti University of Medical Sciences [00-31417-1400/10/14]
dc.description.sponsorshipThis research is extracted from the PharmD thesis of Seyedehdelaram ghalehbandi. This project was supported by the Vice-Chancellor for Research & Technology of Shahid Beheshti University of Medical Sciences (Grant No. 00-31417-1400/10/14). The authors also thank the Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran, for their cooperation in carrying out this study.
dc.identifier.doi10.1016/j.bbr.2022.113785
dc.identifier.issn0166-4328
dc.identifier.issn1872-7549
dc.identifier.orcid0000-0001-6833-0637
dc.identifier.pmid35122794
dc.identifier.scopus2-s2.0-85124190239
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.bbr.2022.113785
dc.identifier.urihttps://hdl.handle.net/11129/12387
dc.identifier.volume423
dc.identifier.wosWOS:000754463800004
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofBehavioural Brain Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectPain
dc.subjectStress
dc.subjectOrexins
dc.subjectOrexin receptors
dc.subjectCA1 region
dc.subjectAcute pain
dc.subjectRats
dc.titleIntra-CA1 injection of orexin receptors antagonism attenuates the stress-induced analgesia in a rat acute pain model
dc.typeArticle

Files